Inflammatory response time course, HUVEC (Wada et al., 2009)
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
SOX3 | hg19_v2_chrX_-_139587225_139587234 | -0.33 | 1.1e-01 | Click! |
SOX2 | hg19_v2_chr3_+_181429704_181429722 | 0.03 | 8.7e-01 | Click! |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 26.1 | GO:0031032 | actomyosin structure organization(GO:0031032) |
0.2 | 9.4 | GO:0035728 | response to hepatocyte growth factor(GO:0035728) |
0.0 | 9.3 | GO:0008360 | regulation of cell shape(GO:0008360) |
1.9 | 7.7 | GO:0050928 | negative regulation of positive chemotaxis(GO:0050928) |
0.0 | 6.9 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.7 | 6.7 | GO:0070495 | regulation of thrombin receptor signaling pathway(GO:0070494) negative regulation of thrombin receptor signaling pathway(GO:0070495) |
2.1 | 6.3 | GO:0035378 | carbon dioxide transmembrane transport(GO:0035378) proximal convoluted tubule development(GO:0072019) metanephric proximal convoluted tubule development(GO:0072229) |
0.2 | 6.2 | GO:0090083 | regulation of inclusion body assembly(GO:0090083) |
0.2 | 6.1 | GO:0003301 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.8 | 5.8 | GO:0048539 | bone marrow development(GO:0048539) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 17.1 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.1 | 14.5 | GO:0005604 | basement membrane(GO:0005604) |
0.1 | 10.7 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.0 | 6.6 | GO:0072562 | blood microparticle(GO:0072562) |
2.1 | 6.3 | GO:0020003 | symbiont-containing vacuole(GO:0020003) symbiont-containing vacuole membrane(GO:0020005) |
0.0 | 6.2 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
0.7 | 6.0 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
0.0 | 5.5 | GO:0030018 | Z disc(GO:0030018) |
0.1 | 5.0 | GO:0005720 | nuclear heterochromatin(GO:0005720) |
0.0 | 5.0 | GO:0032993 | protein-DNA complex(GO:0032993) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 24.3 | GO:0003779 | actin binding(GO:0003779) |
0.0 | 12.9 | GO:0005509 | calcium ion binding(GO:0005509) |
0.1 | 9.5 | GO:0030971 | receptor tyrosine kinase binding(GO:0030971) |
0.2 | 8.7 | GO:0016303 | 1-phosphatidylinositol-3-kinase activity(GO:0016303) |
0.0 | 8.3 | GO:0005525 | GTP binding(GO:0005525) |
0.3 | 8.1 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
2.1 | 6.3 | GO:0035379 | carbon dioxide transmembrane transporter activity(GO:0035379) |
0.1 | 6.2 | GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding(GO:0000980) |
1.2 | 5.8 | GO:0047820 | D-glutamate cyclase activity(GO:0047820) |
0.3 | 5.8 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 13.4 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.2 | 12.8 | PID ERBB1 RECEPTOR PROXIMAL PATHWAY | EGF receptor (ErbB1) signaling pathway |
0.2 | 11.7 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.2 | 8.3 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.1 | 8.2 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.1 | 8.0 | PID E2F PATHWAY | E2F transcription factor network |
0.1 | 5.8 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.1 | 5.5 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.1 | 5.4 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.1 | 5.4 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 9.3 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.5 | 8.8 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.0 | 6.9 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.4 | 6.0 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.1 | 5.4 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.1 | 5.1 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.3 | 4.9 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
0.0 | 4.8 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.0 | 4.7 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
0.0 | 4.4 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |